Literature DB >> 29889755

Salpingectomy Compared With Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Christine Garcia1, Olivia M Moskowitz, Christian A Chisholm, Linda R Duska, Amy L Warren, Genevieve R Lyons, Kate E Pettit.   

Abstract

OBJECTIVE: To estimate whether performance of salpingectomy compared with standard tubal ligation for sterilization at the time of cesarean delivery increases operating time or complication rates.
METHODS: A randomized controlled noninferiority trial was performed at a single academic institution. Women undergoing planned cesarean delivery who desired sterilization were randomized to salpingectomy or standard tubal ligation. The primary outcome was length of time of the sterilization procedure, with the noninferiority margin set at 5 minutes. With a one-sided independent sample t test, to achieve a power of 90% with an α of 0.05, 18 women needed to complete each intervention.
RESULTS: Forty-four women were enrolled, with 19 successfully undergoing salpingectomy and 18 undergoing standard tubal ligation. Salpingectomy could not be completed in 1 of 20 patients (as a result of adhesions). Baseline demographics were equivalent between groups. Salpingectomy procedure time was noninferior to standard tubal ligation, with a mean difference of 0.5 minutes, with a mean sterilization procedure time of 5.6 minutes in the salpingectomy group and 6.1 minutes in the standard tubal ligation group (P <.05, one-sided 95% CI upper bound 1.8 minutes). There was no difference between cesarean delivery with salpingectomy compared with cesarean delivery with standard tubal ligation in median total operating time (60 vs 68 minutes, P=.34) or estimated blood loss (600 vs 700 mL, P=.09). No patients in either group required reoperation or readmission.
CONCLUSION: Salpingectomy procedure time was not longer than standard tubal ligation during cesarean delivery, with a mean difference of 30 seconds. There was a high completion rate for salpingectomy (95%) and no apparent increase in complications. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT03028623.

Entities:  

Mesh:

Year:  2018        PMID: 29889755     DOI: 10.1097/AOG.0000000000002674

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

2.  Women's Reproductive Health Education in Catholic Academic Healthcare Institutions: Time for Transparency, Authenticity, and Reflection.

Authors:  James F Smith
Journal:  Linacre Q       Date:  2020-05-12

3.  The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.

Authors:  Akila Subramaniam; Brett D Einerson; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Gynecol Oncol       Date:  2018-11-23       Impact factor: 5.482

4.  Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.

Authors:  Gillian E Hanley; Jin Niu; Jihee Han; Sharon Fung; Heather Bryant; Janice S Kwon; David G Huntsman; Sarah J Finlayson; Jessica N McAlpine; Dianne Miller; Craig C Earle
Journal:  CMAJ Open       Date:  2022-05-31

5.  Bilateral salpingectomy versus bilateral partial salpingectomy during cesarean delivery.

Authors:  Jose R Duncan; Heather L Jones; Stefanie O Hoffer; Mauro H Schenone; Giancarlo Mari
Journal:  Int J Womens Health       Date:  2018-10-23

6.  Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.

Authors:  Tsutomu Ida; Hiroyuki Fujiwara; Takahiro Kiriu; Yoshimi Taniguchi; Akira Kohyama
Journal:  J Gynecol Oncol       Date:  2019-11       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.